2-(1-Pyrrolidinyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
C15H23BN2O2
1073354-41-2 Copyright (C) 2024 ACS
 20 22  0  0  0  0  0  0  0  0999 V2000
    1.2114    7.3810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    5.7138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    4.4956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2114    2.8282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4415    5.1047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2115    3.7710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2115    6.4384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7515    3.7710    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7515    6.4384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5216    5.1047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9015    5.1047    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
    2.9963    6.3506    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9963    3.8588    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5316    5.8747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5316    4.3347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4415    2.4372    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9100    2.2763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0678    1.0304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5896    0.7700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9234    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 14  1  0  0  0  0
  2 14  1  0  0  0  0
  3 15  1  0  0  0  0
  4 15  1  0  0  0  0
  5  6  2  0  0  0  0
  5  7  1  0  0  0  0
  5 11  1  0  0  0  0
  6  8  1  0  0  0  0
  6 16  1  0  0  0  0
  7  9  2  0  0  0  0
  8 10  2  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 13 15  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
